(Press-News.org) Study Title: Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
Publication: Science Translational Medicine [10.1126/scitranslmed.adf6732]
Dana-Farber Cancer Institute author: Himisha Beltran, MD
Summary: Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks. This process is mediated by molecules called DNA methyltransferases. These tags can alter gene expression in ways that promote tumors to grow and transition into advanced forms of the disease. Researchers from Dana-Farber Cancer Institute discovered, in experiments using patient-derived preclinical models of advanced prostate cancer, that inhibition of DNA methylation with decitabine, a medicine used in the treatment of certain blood cancers, slows tumor growth specifically in a subset of advanced prostate cancers that have neuroendocrine features or loss of the gene RB1. It also results in decreased methylation and elevated expression of a gene that produces a receptor called B7-H3. This receptor is the target of an antibody-drug conjugate currently in evaluation in clinical trials called DS-7300a. In prostate cancers with high levels of B7-H3, DS-7300a was effective on its own. However, DS-7300a alone was less effective when B7-H3 levels are low. The researchers observed that when the drugs are combined, decitabine sensitizes tumors to DS-7300a and improves efficacy.
Impact: Patients with advanced prostate cancer with tumors harboring RB1 gene loss or neuroendocrine features often have a poor prognosis and limited treatment options. This research opens the door to a potential treatment strategy geared specifically toward this population that involves decitabine, B7-H3 targeted therapy, or the two in combination.
Funding: This research was supported by the Japan Society for the Promotion of Science, the Prostate Cancer Foundation, the United States Department of Defense, the National Cancer Center, the National Institutes of Health, and Daiichi Sankyo.
END
Treatment strategy for certain advanced prostate cancers shows promise in preclinical models
2023-11-15
ELSE PRESS RELEASES FROM THIS DATE:
Devil in the detail – What corporations aren’t disclosing about their C02 emissions
2023-11-15
A new study estimates most corporations are not reporting the full scope of their carbon footprint with many claiming to be ‘green’ despite a lack of reporting on Scope 3 key categories.
Though CO2 reporting is currently voluntary for most firms, corporations are under pressure from investors, regulators, politicians, non-profit organisations and other stakeholders to disclose and reduce greenhouse gas emissions (GHG).
The standard for greenhouse gas accounting, the Greenhouse Gas Protocol, is used worldwide to measure a company’s total carbon footprint with three levels of reporting.
The first measures the GHG emissions directly produced by a company ...
New ‘patch’ uses natural body motion to fix disc herniation
2023-11-15
PHILADELPHIA— A new biologic “patch” that is activated by a person’s natural motion could be the key to fixing herniated discs in people’s backs, according to researchers at the Perelman School of Medicine at the University of Pennsylvania and the CMC VA Medical Center (CMCVAMC). Combining years of work from many different projects, the “tension-activated repair patches” (TARPs) provide controlled release of an anti-inflammatory molecule called anakinra from microcapsules over time, which helped ...
The liking gap is real for second language English speakers, new Concordia research shows
2023-11-15
A new study from Concordia’s Applied Linguistics Lab suggests that most people are usually overly harsh on themselves when speaking in a second language.
Writing in the journal Languages, PhD student Rachael Lindberg and her co-authors build on the previous understanding of individuals’ metaperception—a person’s idea of how they are perceived by others.
The idea that people frequently underestimate how likeable they are, known as the Liking Gap, ...
Study reveals link between neighborhood environmental burden and risk of cardiovascular disease
2023-11-15
BOSTON – A national study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) demonstrates that neighborhood exposure to environmental hazards is significantly associated with poor cardiovascular health across the United States. The study, presented at the American Heart Association Scientific Sessions and simultaneously published in JAMA Cardiology, found that greater cumulative environmental burden (e.g., air pollution, nearby hazardous/toxic sites, poor built environment) was linked ...
Cancer: Discovery of the mechanisms regulating cancer formation
2023-11-15
To form a cancer, cells need to accumulate oncogenic mutations that confer tumor-initiating properties. However, recent evidence has shown that oncogenic mutations occur at a surprisingly high frequency in normal tissues, suggesting that mutations alone are not sufficient to drive cancer formation and that other mechanisms should promote or restrain oncogene-expressing cells from progressing into invasive tumors.
In a study published in Nature, researchers led by Prof. Cédric Blanpain, MD/PhD, investigator of the WEL Research Institute, Director of the Stem Cells and Cancer Laboratory and Professor at the Université ...
Researchers halt progression in Parkinson's disease mouse model
2023-11-15
BOSTON – In a study published in Nature Communications, investigators at Beth Israel Deaconess Medical Center (BIDMC) shed new light on key cellular processes involved in the progression of Parkinson’s disease (PD). Affecting around 10 million people worldwide, Parkinson's disease is a neurodegenerative disorder caused by the progressive loss of the group of brain cells responsible for producing dopamine, a neurotransmitter that plays a critical role in regulating movement and coordination. As these neurons degenerate and dopamine levels decrease, individuals with Parkinson's disease experience a wide range of symptoms, including ...
Study: People with obesity burn less energy during day
2023-11-15
PORTLAND, Oregon – Weight influences how and when bodies burn energy, new research indicates.
An Oregon Health & Science University study published in the journal Obesity found people who have a healthy weight use more energy during the day, when most people are active and eat, while those who have obesity spend more energy during the night, when most people sleep. The study also found that during the day, those with obesity have higher levels of the hormone insulin — a sign that the body is working harder to use glucose, an energy-packed sugar.
“It was surprising to learn how dramatically the timing of when our bodies burn energy differed in ...
Female MP pioneers lost unique appeal to voters because of increasing party control over campaigning, study shows
2023-11-15
Early women parliamentary candidates found it harder to make unique appeals to represent the ‘woman’s point of view’ over time because of increasing national control over campaigning, a new study shows.
The increasing trend for men to present themselves as diligent workers for their constituents’ welfare and keen supporters for social reform also meant they challenged the idea that only female politicians could represent their sex properly in parliament, researchers have found.
The first women parliamentary candidates built on the suffrage campaigners’ argument that there was a distinctive woman’s point of ...
Can gene expression predict if a brain tumor is likely to grow back?
2023-11-15
Doctors often prescribe radiation along with surgery to treat a brain tumor called meningioma that originates in the protective membranes surrounding the brain. But side effects from radiation can be serious, including memory loss and cognitive decline, so it’s important to know which patients really need it.
Now, researchers at UC San Francisco and Northwestern Medicine, in collaboration with 10 other medical centers, have found a highly accurate way to predict the best treatment for patients based ...
Microbes could help reduce the need for chemical fertilizers
2023-11-15
Production of chemical fertilizers accounts for about 1.5 percent of the world’s greenhouse gas emissions. MIT chemists hope to help reduce that carbon footprint by replacing some chemical fertilizer with a more sustainable source — bacteria.
Bacteria that can convert nitrogen gas to ammonia could not only provide nutrients that plants need, but also help regenerate soil and protect plants from pests. However, these bacteria are sensitive to heat and humidity, so it’s difficult to scale up their manufacture and ship them to farms.
To overcome that obstacle, ...